Descovy 200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FCZLL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,562
Award facts
- Contract value 100% obligated
- $27,561.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, valued at $27,561.95 for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This firm fixed price contract, which is a child order under a larger indefinite delivery contract, represents a non-competitive set-aside delivery on an open basis. The contract is scheduled for completion by August 13, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used primarily for HIV prevention and treatment, reflecting the Defense Logistics Agency Medical Supply Chain's ongoing procurement of specialized pharmaceutical products to support military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999.99 million through December 2026. This prime vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support Defense Health Agency programs and other federal healthcare systems worldwide. As a major pharmaceutical distributor and critical vendor in the federal medical procurement ecosystem, AmerisourceBergen has demonstrated consistent capability to fulfill federal requirements across multiple therapeutic domains through competitively awarded contracts with the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DB25FCZLL?
SPE2DB25FCZLL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 12, 2025.
How much is contract SPE2DB25FCZLL worth?
The government has obligated $27,562 on SPE2DB25FCZLL.
Is contract SPE2DB25FCZLL an order under another contract?
Yes. SPE2DB25FCZLL is a delivery order under SPE2DB24D1205, an indefinite delivery contract.
Was contract SPE2DB25FCZLL competed?
The extent of competition for SPE2DB25FCZLL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award